Acurx Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
259 Liberty Ave, Staten Island, New York...Phone Number
(917) 533-1469Website
www.acurxpharma.comRevenue
-Stock Symbol
ACXPIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Acurx Pharmaceuticals
Acurx Pharmaceuticals, Inc. is a New York-based publicly held clinical-stage biopharmaceutical company developing antibiotics for infections caused by priority bacterial pathogens. Its research focuses on DNA polymerase IIIC inhibition, with lead candidate ibezapolstat in clinical trials for C. difficile infections and additional early-stage antibiotic programs targeting difficult-to-treat Gram-positive infections. The company trades on the public market under the ticker ACXP.Explore more
Acurx Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acurx Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Acurx Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Acurx Pharmaceuticals has new funding data
Check if Acurx Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Acurx Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Acurx Pharmaceuticals
Check out if Acurx Pharmaceuticals is spiking on competitors!
Acurx Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Acurx Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Acurx Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Acurx Pharmaceuticals
Compare insights from companies similar to Acurx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acurx Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Acurx Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Acurx Pharmaceuticals.
Acurx Pharmaceuticals Tech Stack
A closer look at the technologies used by Acurx Pharmaceuticals
Most Recent Scoops
Person-Based
Regulations
Person-Based
Pharmaceuticals, Clinical Operations
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Pharmaceuticals, Clinical Operations
Acurx Pharmaceuticals News & Media
Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
The proposed proprietary name, or brand name, CIFBEZY has received conditional acceptance from the FDA and also federal trademark allowance from the USPTO These initial milestones will form the basis for the commercial identity of Acurx's lead product candidate, ibezapolstat, as the...Acurx Pharmaceuticals, Inc. (ACXP) Q2 2026 Earnings Call Transcript
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2026 Earnings Call August 14, 2026 8:00 AM EDTCompany ParticipantsRobert Shawah - Co-Founder & CFODavid Luci -...Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
STATEN ISLAND, N.Y., Aug. 14, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and...Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
STATEN ISLAND, N.Y., Aug. 12, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial infections, today announced that the Japan...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acurx Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Acurx Pharmaceuticals, Inc. is a New York-based publicly held clinical-stage biopharmaceutical company developing antibiotics for infections caused by priority bacterial pathogens. Its research focuses on DNA polymerase IIIC inhibition, with lead candidate ibezapolstat in clinical trials for C. difficile infections and additional early-stage antibi... Read More
